| 3.6 |
21.4 |
GO:0002760 |
positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
| 2.7 |
8.1 |
GO:0043012 |
regulation of fusion of sperm to egg plasma membrane(GO:0043012) |
| 2.5 |
7.4 |
GO:0097195 |
pilomotor reflex(GO:0097195) |
| 2.2 |
9.0 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 1.9 |
11.7 |
GO:0045110 |
intermediate filament bundle assembly(GO:0045110) |
| 1.9 |
11.5 |
GO:1904274 |
tricellular tight junction assembly(GO:1904274) |
| 1.7 |
7.0 |
GO:0032771 |
regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
| 1.7 |
1.7 |
GO:2000696 |
regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
| 1.7 |
1.7 |
GO:0071451 |
cellular response to oxygen radical(GO:0071450) cellular response to superoxide(GO:0071451) |
| 1.4 |
4.2 |
GO:0060054 |
positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
| 1.4 |
4.2 |
GO:1904784 |
NLRP1 inflammasome complex assembly(GO:1904784) |
| 1.4 |
5.5 |
GO:0050717 |
positive regulation of interleukin-1 alpha secretion(GO:0050717) |
| 1.3 |
16.1 |
GO:0035986 |
senescence-associated heterochromatin focus assembly(GO:0035986) |
| 1.3 |
8.9 |
GO:1902164 |
regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902164) |
| 1.3 |
3.8 |
GO:0042938 |
dipeptide transport(GO:0042938) |
| 1.3 |
5.0 |
GO:0051710 |
cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
| 1.2 |
3.6 |
GO:0034970 |
histone H3-R2 methylation(GO:0034970) |
| 1.2 |
4.8 |
GO:0060448 |
dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
| 1.2 |
5.9 |
GO:0033123 |
positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
| 1.2 |
5.8 |
GO:1902534 |
single-organism membrane invagination(GO:1902534) |
| 1.2 |
3.5 |
GO:0002025 |
vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
| 1.1 |
18.0 |
GO:0048672 |
positive regulation of collateral sprouting(GO:0048672) |
| 1.1 |
3.4 |
GO:0043315 |
positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
| 1.1 |
3.3 |
GO:2001226 |
negative regulation of chloride transport(GO:2001226) |
| 1.1 |
5.5 |
GO:2001023 |
regulation of response to drug(GO:2001023) |
| 1.1 |
14.9 |
GO:0036484 |
trunk segmentation(GO:0035290) trunk neural crest cell migration(GO:0036484) ventral trunk neural crest cell migration(GO:0036486) neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
| 1.1 |
3.2 |
GO:0003147 |
neural crest cell migration involved in heart formation(GO:0003147) anterior neural tube closure(GO:0061713) |
| 1.0 |
11.2 |
GO:0031944 |
negative regulation of glucocorticoid metabolic process(GO:0031944) negative regulation of glucocorticoid biosynthetic process(GO:0031947) negative regulation of steroid hormone biosynthetic process(GO:0090032) |
| 1.0 |
4.0 |
GO:1905205 |
positive regulation of connective tissue replacement(GO:1905205) |
| 1.0 |
3.0 |
GO:0070638 |
nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
| 1.0 |
2.9 |
GO:0048627 |
myoblast development(GO:0048627) |
| 1.0 |
1.9 |
GO:2000412 |
positive regulation of thymocyte migration(GO:2000412) |
| 1.0 |
2.9 |
GO:0038190 |
neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) regulation of protein kinase D signaling(GO:1903570) positive regulation of protein kinase D signaling(GO:1903572) |
| 0.9 |
6.6 |
GO:0030035 |
microspike assembly(GO:0030035) |
| 0.9 |
9.0 |
GO:0002480 |
antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
| 0.9 |
9.0 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.9 |
3.6 |
GO:1903691 |
positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
| 0.9 |
6.2 |
GO:0072675 |
multinuclear osteoclast differentiation(GO:0072674) osteoclast fusion(GO:0072675) |
| 0.8 |
5.9 |
GO:0071279 |
cellular response to cobalt ion(GO:0071279) |
| 0.8 |
6.6 |
GO:0061198 |
fungiform papilla formation(GO:0061198) |
| 0.8 |
0.8 |
GO:0060594 |
mammary gland specification(GO:0060594) |
| 0.8 |
0.8 |
GO:0003197 |
endocardial cushion development(GO:0003197) |
| 0.8 |
4.0 |
GO:0060708 |
spongiotrophoblast differentiation(GO:0060708) |
| 0.8 |
2.4 |
GO:0019364 |
NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
| 0.8 |
3.9 |
GO:0061528 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) aspartate secretion(GO:0061528) regulation of aspartate secretion(GO:1904448) positive regulation of aspartate secretion(GO:1904450) |
| 0.8 |
3.9 |
GO:0097114 |
NMDA glutamate receptor clustering(GO:0097114) |
| 0.8 |
2.3 |
GO:1904328 |
regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
| 0.8 |
3.1 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.8 |
2.3 |
GO:0051562 |
negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
| 0.8 |
2.3 |
GO:0002585 |
positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) |
| 0.7 |
3.7 |
GO:0030311 |
poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
| 0.7 |
6.0 |
GO:0032929 |
negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 |
28.0 |
GO:0042744 |
hydrogen peroxide catabolic process(GO:0042744) |
| 0.7 |
3.7 |
GO:0043553 |
negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
| 0.7 |
2.2 |
GO:0060545 |
positive regulation of necroptotic process(GO:0060545) |
| 0.7 |
4.3 |
GO:0030421 |
defecation(GO:0030421) |
| 0.7 |
6.4 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.7 |
2.1 |
GO:0002856 |
negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
| 0.7 |
2.8 |
GO:2000490 |
negative regulation of hepatic stellate cell activation(GO:2000490) |
| 0.7 |
1.4 |
GO:0048843 |
negative regulation of axon extension involved in axon guidance(GO:0048843) |
| 0.7 |
3.4 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.7 |
1.4 |
GO:0002337 |
B-1a B cell differentiation(GO:0002337) |
| 0.7 |
4.6 |
GO:1903575 |
cornified envelope assembly(GO:1903575) |
| 0.7 |
2.6 |
GO:1903722 |
negative regulation of exosomal secretion(GO:1903542) regulation of centriole elongation(GO:1903722) |
| 0.7 |
2.0 |
GO:0035526 |
retrograde transport, plasma membrane to Golgi(GO:0035526) |
| 0.6 |
9.7 |
GO:0098887 |
neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
| 0.6 |
3.0 |
GO:1900104 |
hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.6 |
1.8 |
GO:0060697 |
positive regulation of phospholipid catabolic process(GO:0060697) |
| 0.6 |
4.8 |
GO:1902952 |
positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.6 |
2.4 |
GO:0010593 |
negative regulation of lamellipodium assembly(GO:0010593) |
| 0.6 |
10.6 |
GO:0015816 |
glycine transport(GO:0015816) |
| 0.6 |
6.8 |
GO:0070445 |
oligodendrocyte progenitor proliferation(GO:0070444) regulation of oligodendrocyte progenitor proliferation(GO:0070445) |
| 0.6 |
1.7 |
GO:0038060 |
nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
| 0.6 |
2.8 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.6 |
1.7 |
GO:0019858 |
cytosine metabolic process(GO:0019858) |
| 0.5 |
0.5 |
GO:0072164 |
mesonephric epithelium development(GO:0072163) mesonephric tubule development(GO:0072164) |
| 0.5 |
2.1 |
GO:0045763 |
negative regulation of cellular amino acid metabolic process(GO:0045763) |
| 0.5 |
2.6 |
GO:0044752 |
response to human chorionic gonadotropin(GO:0044752) |
| 0.5 |
0.5 |
GO:0048852 |
diencephalon morphogenesis(GO:0048852) |
| 0.5 |
5.3 |
GO:0070487 |
monocyte aggregation(GO:0070487) |
| 0.5 |
1.6 |
GO:1904247 |
positive regulation of polynucleotide adenylyltransferase activity(GO:1904247) |
| 0.5 |
4.7 |
GO:0048050 |
post-embryonic eye morphogenesis(GO:0048050) |
| 0.5 |
1.5 |
GO:0051102 |
DNA ligation involved in DNA recombination(GO:0051102) |
| 0.5 |
3.1 |
GO:0061343 |
cell adhesion involved in heart morphogenesis(GO:0061343) |
| 0.5 |
1.0 |
GO:1901074 |
regulation of engulfment of apoptotic cell(GO:1901074) |
| 0.5 |
5.6 |
GO:0048102 |
autophagic cell death(GO:0048102) |
| 0.5 |
7.5 |
GO:1902902 |
negative regulation of autophagosome assembly(GO:1902902) |
| 0.5 |
1.5 |
GO:0033341 |
regulation of collagen binding(GO:0033341) |
| 0.5 |
12.3 |
GO:0060670 |
branching involved in labyrinthine layer morphogenesis(GO:0060670) |
| 0.5 |
1.9 |
GO:0006566 |
threonine metabolic process(GO:0006566) |
| 0.5 |
1.9 |
GO:0060166 |
olfactory pit development(GO:0060166) |
| 0.5 |
2.4 |
GO:0061502 |
early endosome to recycling endosome transport(GO:0061502) |
| 0.5 |
2.4 |
GO:0035617 |
stress granule disassembly(GO:0035617) |
| 0.5 |
2.3 |
GO:0045658 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.5 |
1.4 |
GO:2000742 |
anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 0.5 |
1.8 |
GO:0061357 |
positive regulation of Wnt protein secretion(GO:0061357) |
| 0.5 |
1.8 |
GO:0000023 |
maltose metabolic process(GO:0000023) |
| 0.5 |
3.2 |
GO:0010986 |
positive regulation of lipoprotein particle clearance(GO:0010986) |
| 0.5 |
1.4 |
GO:1904404 |
cellular response to vitamin B1(GO:0071301) response to formaldehyde(GO:1904404) |
| 0.4 |
0.9 |
GO:0006788 |
heme oxidation(GO:0006788) |
| 0.4 |
1.8 |
GO:0019072 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.4 |
6.6 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.4 |
0.4 |
GO:0032222 |
regulation of synaptic transmission, cholinergic(GO:0032222) positive regulation of synaptic transmission, cholinergic(GO:0032224) |
| 0.4 |
2.2 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.4 |
3.4 |
GO:0030578 |
PML body organization(GO:0030578) |
| 0.4 |
2.6 |
GO:0010760 |
negative regulation of macrophage chemotaxis(GO:0010760) |
| 0.4 |
3.0 |
GO:0015824 |
proline transport(GO:0015824) proline transmembrane transport(GO:0035524) |
| 0.4 |
1.3 |
GO:0032289 |
central nervous system myelin formation(GO:0032289) |
| 0.4 |
3.4 |
GO:0060753 |
regulation of mast cell chemotaxis(GO:0060753) |
| 0.4 |
0.8 |
GO:0097212 |
lysosomal membrane organization(GO:0097212) |
| 0.4 |
1.2 |
GO:0046586 |
regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 0.4 |
0.8 |
GO:1900006 |
positive regulation of dendrite development(GO:1900006) |
| 0.4 |
2.4 |
GO:0014718 |
positive regulation of satellite cell activation involved in skeletal muscle regeneration(GO:0014718) |
| 0.4 |
6.7 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.4 |
0.8 |
GO:1900220 |
semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
| 0.4 |
0.4 |
GO:0097676 |
histone H3-K36 dimethylation(GO:0097676) |
| 0.4 |
5.8 |
GO:0002191 |
cap-dependent translational initiation(GO:0002191) |
| 0.4 |
7.4 |
GO:0061302 |
smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.4 |
2.3 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.4 |
4.2 |
GO:1902414 |
protein localization to cell junction(GO:1902414) |
| 0.4 |
1.9 |
GO:0039534 |
negative regulation of MDA-5 signaling pathway(GO:0039534) |
| 0.4 |
6.1 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.4 |
3.0 |
GO:1905232 |
cellular response to L-glutamate(GO:1905232) |
| 0.4 |
0.8 |
GO:0071542 |
dopaminergic neuron differentiation(GO:0071542) |
| 0.4 |
4.6 |
GO:0046598 |
positive regulation of viral entry into host cell(GO:0046598) |
| 0.4 |
2.3 |
GO:0018343 |
protein farnesylation(GO:0018343) |
| 0.4 |
1.9 |
GO:1903906 |
plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
| 0.4 |
1.1 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.4 |
1.1 |
GO:0048203 |
vesicle targeting, trans-Golgi to endosome(GO:0048203) |
| 0.4 |
1.5 |
GO:0051563 |
smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.4 |
2.6 |
GO:0035879 |
plasma membrane lactate transport(GO:0035879) |
| 0.4 |
1.1 |
GO:0060399 |
positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
| 0.4 |
1.8 |
GO:0071494 |
cellular response to UV-C(GO:0071494) |
| 0.4 |
0.4 |
GO:0090086 |
negative regulation of protein deubiquitination(GO:0090086) regulation of protein K48-linked deubiquitination(GO:1903093) negative regulation of protein K48-linked deubiquitination(GO:1903094) negative regulation of ubiquitin-specific protease activity(GO:2000157) |
| 0.4 |
13.1 |
GO:0031581 |
hemidesmosome assembly(GO:0031581) |
| 0.4 |
1.8 |
GO:0014886 |
transition between slow and fast fiber(GO:0014886) |
| 0.4 |
2.9 |
GO:0018344 |
protein geranylgeranylation(GO:0018344) |
| 0.4 |
0.4 |
GO:0010940 |
positive regulation of necrotic cell death(GO:0010940) |
| 0.4 |
1.8 |
GO:0003366 |
cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
| 0.4 |
1.4 |
GO:0090135 |
actin filament branching(GO:0090135) |
| 0.4 |
0.7 |
GO:0048003 |
antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
| 0.4 |
2.1 |
GO:0071543 |
diadenosine polyphosphate catabolic process(GO:0015961) diphosphoinositol polyphosphate metabolic process(GO:0071543) diadenosine pentaphosphate metabolic process(GO:1901906) diadenosine pentaphosphate catabolic process(GO:1901907) diadenosine hexaphosphate metabolic process(GO:1901908) diadenosine hexaphosphate catabolic process(GO:1901909) adenosine 5'-(hexahydrogen pentaphosphate) metabolic process(GO:1901910) adenosine 5'-(hexahydrogen pentaphosphate) catabolic process(GO:1901911) |
| 0.4 |
1.8 |
GO:0042441 |
eye pigment biosynthetic process(GO:0006726) eye pigment metabolic process(GO:0042441) pigment metabolic process involved in developmental pigmentation(GO:0043324) pigment metabolic process involved in pigmentation(GO:0043474) |
| 0.4 |
1.1 |
GO:1902490 |
regulation of sperm capacitation(GO:1902490) |
| 0.4 |
0.7 |
GO:1900155 |
regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
| 0.3 |
3.1 |
GO:0086073 |
bundle of His cell-Purkinje myocyte adhesion involved in cell communication(GO:0086073) |
| 0.3 |
0.7 |
GO:0046732 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
| 0.3 |
3.8 |
GO:0034128 |
negative regulation of MyD88-independent toll-like receptor signaling pathway(GO:0034128) |
| 0.3 |
0.3 |
GO:0035270 |
endocrine system development(GO:0035270) |
| 0.3 |
3.8 |
GO:0070197 |
meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
| 0.3 |
4.8 |
GO:1902951 |
negative regulation of dendritic spine maintenance(GO:1902951) |
| 0.3 |
1.4 |
GO:0045399 |
response to molecule of fungal origin(GO:0002238) regulation of interleukin-3 production(GO:0032672) positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) cellular response to molecule of fungal origin(GO:0071226) |
| 0.3 |
1.4 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.3 |
1.0 |
GO:0001579 |
medium-chain fatty acid transport(GO:0001579) |
| 0.3 |
1.7 |
GO:0009183 |
purine deoxyribonucleoside diphosphate biosynthetic process(GO:0009183) |
| 0.3 |
0.7 |
GO:1903519 |
apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
| 0.3 |
0.3 |
GO:0070345 |
negative regulation of fat cell proliferation(GO:0070345) |
| 0.3 |
2.0 |
GO:0060744 |
thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
| 0.3 |
3.3 |
GO:2001181 |
positive regulation of interleukin-10 secretion(GO:2001181) |
| 0.3 |
1.7 |
GO:0051892 |
negative regulation of cardioblast differentiation(GO:0051892) regulation of cardiac muscle cell myoblast differentiation(GO:2000690) negative regulation of cardiac muscle cell myoblast differentiation(GO:2000691) |
| 0.3 |
1.7 |
GO:0042412 |
taurine biosynthetic process(GO:0042412) |
| 0.3 |
2.0 |
GO:0010643 |
cell communication by chemical coupling(GO:0010643) |
| 0.3 |
0.3 |
GO:0045838 |
positive regulation of membrane potential(GO:0045838) |
| 0.3 |
1.0 |
GO:1904815 |
negative regulation of protein localization to chromosome, telomeric region(GO:1904815) |
| 0.3 |
0.6 |
GO:1904245 |
regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.3 |
3.9 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.3 |
4.8 |
GO:0001778 |
plasma membrane repair(GO:0001778) |
| 0.3 |
1.3 |
GO:0006218 |
uridine catabolic process(GO:0006218) |
| 0.3 |
1.0 |
GO:2000864 |
estrogen secretion(GO:0035937) estradiol secretion(GO:0035938) regulation of estrogen secretion(GO:2000861) regulation of estradiol secretion(GO:2000864) |
| 0.3 |
1.0 |
GO:0072361 |
regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
| 0.3 |
0.6 |
GO:0001300 |
chronological cell aging(GO:0001300) |
| 0.3 |
3.8 |
GO:2000576 |
positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.3 |
0.9 |
GO:0044861 |
protein transport into plasma membrane raft(GO:0044861) |
| 0.3 |
1.9 |
GO:1902953 |
positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.3 |
0.9 |
GO:0034148 |
regulation of toll-like receptor 5 signaling pathway(GO:0034147) negative regulation of toll-like receptor 5 signaling pathway(GO:0034148) regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070428) negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070429) tolerance induction to lipopolysaccharide(GO:0072573) negative regulation of CD40 signaling pathway(GO:2000349) |
| 0.3 |
1.9 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.3 |
0.9 |
GO:0035038 |
female pronucleus assembly(GO:0035038) |
| 0.3 |
2.2 |
GO:0031642 |
negative regulation of myelination(GO:0031642) |
| 0.3 |
2.5 |
GO:0010836 |
negative regulation of protein ADP-ribosylation(GO:0010836) |
| 0.3 |
1.2 |
GO:1904806 |
regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
| 0.3 |
1.2 |
GO:0050902 |
leukocyte adhesive activation(GO:0050902) |
| 0.3 |
1.8 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.3 |
0.9 |
GO:1903526 |
negative regulation of membrane tubulation(GO:1903526) |
| 0.3 |
1.8 |
GO:0090038 |
negative regulation of protein kinase C signaling(GO:0090038) |
| 0.3 |
3.6 |
GO:0097119 |
postsynaptic density protein 95 clustering(GO:0097119) |
| 0.3 |
1.8 |
GO:1903588 |
negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 0.3 |
2.4 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.3 |
0.6 |
GO:1902746 |
regulation of lens fiber cell differentiation(GO:1902746) |
| 0.3 |
1.2 |
GO:0097045 |
phosphatidylserine exposure on blood platelet(GO:0097045) |
| 0.3 |
3.2 |
GO:0055059 |
asymmetric neuroblast division(GO:0055059) |
| 0.3 |
2.0 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.3 |
2.3 |
GO:0031914 |
negative regulation of synaptic plasticity(GO:0031914) |
| 0.3 |
7.6 |
GO:0046596 |
regulation of viral entry into host cell(GO:0046596) |
| 0.3 |
0.3 |
GO:1901204 |
regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901204) negative regulation of adrenergic receptor signaling pathway involved in heart process(GO:1901205) |
| 0.3 |
2.0 |
GO:0060449 |
bud elongation involved in lung branching(GO:0060449) |
| 0.3 |
1.4 |
GO:0010193 |
response to ozone(GO:0010193) |
| 0.3 |
1.9 |
GO:0072385 |
minus-end-directed organelle transport along microtubule(GO:0072385) |
| 0.3 |
3.3 |
GO:0021759 |
globus pallidus development(GO:0021759) |
| 0.3 |
0.3 |
GO:0042823 |
pyridoxal phosphate biosynthetic process(GO:0042823) |
| 0.3 |
0.8 |
GO:0030860 |
regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.3 |
2.8 |
GO:0072656 |
maintenance of protein location in mitochondrion(GO:0072656) |
| 0.3 |
1.1 |
GO:0042796 |
snRNA transcription from RNA polymerase III promoter(GO:0042796) |
| 0.3 |
0.8 |
GO:0032918 |
polyamine acetylation(GO:0032917) spermidine acetylation(GO:0032918) |
| 0.3 |
0.8 |
GO:0060463 |
lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
| 0.3 |
3.0 |
GO:0097167 |
circadian regulation of translation(GO:0097167) |
| 0.3 |
2.7 |
GO:0006526 |
arginine biosynthetic process(GO:0006526) |
| 0.3 |
0.5 |
GO:0036518 |
chemorepulsion of dopaminergic neuron axon(GO:0036518) |
| 0.3 |
1.4 |
GO:0006051 |
mannosamine metabolic process(GO:0006050) N-acetylmannosamine metabolic process(GO:0006051) |
| 0.3 |
1.1 |
GO:0006850 |
mitochondrial pyruvate transport(GO:0006850) mitochondrial pyruvate transmembrane transport(GO:1902361) |
| 0.3 |
1.3 |
GO:0018101 |
protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
| 0.3 |
1.3 |
GO:1904693 |
midbrain morphogenesis(GO:1904693) |
| 0.3 |
2.1 |
GO:0032485 |
Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
| 0.3 |
2.1 |
GO:0072554 |
blood vessel lumenization(GO:0072554) positive regulation of ephrin receptor signaling pathway(GO:1901189) positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:1901297) positive regulation of canonical Wnt signaling pathway involved in heart development(GO:1905068) |
| 0.3 |
2.4 |
GO:0006049 |
UDP-N-acetylglucosamine catabolic process(GO:0006049) |
| 0.3 |
2.9 |
GO:0042420 |
dopamine catabolic process(GO:0042420) |
| 0.3 |
1.3 |
GO:0085032 |
modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
| 0.3 |
0.5 |
GO:0035397 |
helper T cell enhancement of adaptive immune response(GO:0035397) |
| 0.3 |
3.9 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.3 |
2.6 |
GO:0051665 |
membrane raft localization(GO:0051665) |
| 0.3 |
1.5 |
GO:0097021 |
lymphocyte migration into lymphoid organs(GO:0097021) |
| 0.3 |
0.3 |
GO:0051835 |
positive regulation of synapse structural plasticity(GO:0051835) |
| 0.3 |
1.0 |
GO:0010936 |
negative regulation of macrophage cytokine production(GO:0010936) |
| 0.2 |
0.7 |
GO:0046963 |
3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
| 0.2 |
0.2 |
GO:0039519 |
modulation by virus of host autophagy(GO:0039519) |
| 0.2 |
1.2 |
GO:1902455 |
negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 |
3.7 |
GO:0097264 |
self proteolysis(GO:0097264) |
| 0.2 |
1.7 |
GO:1904381 |
Golgi apparatus mannose trimming(GO:1904381) |
| 0.2 |
0.7 |
GO:0061091 |
regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
| 0.2 |
4.3 |
GO:1901621 |
negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
| 0.2 |
0.7 |
GO:1900073 |
regulation of neuromuscular synaptic transmission(GO:1900073) positive regulation of neuromuscular synaptic transmission(GO:1900075) |
| 0.2 |
0.7 |
GO:0007202 |
activation of phospholipase C activity(GO:0007202) |
| 0.2 |
1.2 |
GO:1904579 |
response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.2 |
1.2 |
GO:0010847 |
regulation of chromatin assembly(GO:0010847) |
| 0.2 |
1.0 |
GO:0015670 |
carbon dioxide transport(GO:0015670) |
| 0.2 |
0.5 |
GO:0045715 |
negative regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045715) |
| 0.2 |
1.0 |
GO:0000294 |
nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
| 0.2 |
1.2 |
GO:0038098 |
sequestering of BMP from receptor via BMP binding(GO:0038098) |
| 0.2 |
0.7 |
GO:0030432 |
peristalsis(GO:0030432) |
| 0.2 |
1.2 |
GO:0008611 |
ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.2 |
0.7 |
GO:0021503 |
neural fold bending(GO:0021503) |
| 0.2 |
4.5 |
GO:0050812 |
regulation of acyl-CoA biosynthetic process(GO:0050812) |
| 0.2 |
2.1 |
GO:0046836 |
glycolipid transport(GO:0046836) |
| 0.2 |
0.7 |
GO:0010499 |
proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
| 0.2 |
3.1 |
GO:0036066 |
protein O-linked fucosylation(GO:0036066) |
| 0.2 |
0.9 |
GO:0042247 |
morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
| 0.2 |
3.0 |
GO:0043542 |
endothelial cell migration(GO:0043542) |
| 0.2 |
0.5 |
GO:0090370 |
negative regulation of cholesterol efflux(GO:0090370) |
| 0.2 |
0.7 |
GO:0060856 |
establishment of blood-brain barrier(GO:0060856) |
| 0.2 |
0.2 |
GO:0035331 |
negative regulation of hippo signaling(GO:0035331) |
| 0.2 |
0.9 |
GO:0098582 |
innate vocalization behavior(GO:0098582) |
| 0.2 |
1.6 |
GO:2000609 |
regulation of thyroid hormone generation(GO:2000609) |
| 0.2 |
0.7 |
GO:0032747 |
positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 |
3.2 |
GO:0007614 |
short-term memory(GO:0007614) |
| 0.2 |
6.9 |
GO:0032331 |
negative regulation of chondrocyte differentiation(GO:0032331) |
| 0.2 |
1.1 |
GO:0046351 |
disaccharide biosynthetic process(GO:0046351) |
| 0.2 |
2.3 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.2 |
3.0 |
GO:0010839 |
negative regulation of keratinocyte proliferation(GO:0010839) |
| 0.2 |
3.2 |
GO:2000427 |
positive regulation of apoptotic cell clearance(GO:2000427) |
| 0.2 |
0.2 |
GO:0072387 |
flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.2 |
2.5 |
GO:0070970 |
interleukin-2 secretion(GO:0070970) |
| 0.2 |
1.4 |
GO:0061042 |
vascular wound healing(GO:0061042) |
| 0.2 |
1.8 |
GO:0046952 |
ketone body catabolic process(GO:0046952) |
| 0.2 |
2.7 |
GO:0032926 |
negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.2 |
0.7 |
GO:0044342 |
type B pancreatic cell proliferation(GO:0044342) |
| 0.2 |
2.7 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) |
| 0.2 |
0.9 |
GO:0060492 |
foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
| 0.2 |
2.2 |
GO:0002457 |
T cell antigen processing and presentation(GO:0002457) |
| 0.2 |
2.5 |
GO:0018377 |
protein myristoylation(GO:0018377) |
| 0.2 |
0.9 |
GO:1904180 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
4.0 |
GO:0090361 |
platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
| 0.2 |
2.0 |
GO:0007406 |
negative regulation of neuroblast proliferation(GO:0007406) |
| 0.2 |
0.4 |
GO:0023021 |
termination of signal transduction(GO:0023021) |
| 0.2 |
0.9 |
GO:1990785 |
response to water-immersion restraint stress(GO:1990785) |
| 0.2 |
2.4 |
GO:0016191 |
synaptic vesicle uncoating(GO:0016191) |
| 0.2 |
0.7 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.2 |
1.1 |
GO:0006346 |
methylation-dependent chromatin silencing(GO:0006346) |
| 0.2 |
0.6 |
GO:0006990 |
positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
| 0.2 |
1.1 |
GO:0021622 |
optic cup structural organization(GO:0003409) oculomotor nerve morphogenesis(GO:0021622) oculomotor nerve formation(GO:0021623) |
| 0.2 |
1.1 |
GO:0070945 |
neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
| 0.2 |
4.9 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.2 |
0.6 |
GO:1902774 |
late endosome to lysosome transport(GO:1902774) |
| 0.2 |
0.4 |
GO:0098727 |
stem cell population maintenance(GO:0019827) maintenance of cell number(GO:0098727) |
| 0.2 |
1.1 |
GO:0016240 |
autophagosome docking(GO:0016240) |
| 0.2 |
0.8 |
GO:0010637 |
negative regulation of mitochondrial fusion(GO:0010637) |
| 0.2 |
2.7 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.2 |
0.4 |
GO:0003431 |
growth plate cartilage chondrocyte development(GO:0003431) |
| 0.2 |
0.4 |
GO:0032912 |
negative regulation of transforming growth factor beta2 production(GO:0032912) |
| 0.2 |
1.5 |
GO:0051684 |
maintenance of Golgi location(GO:0051684) |
| 0.2 |
0.8 |
GO:2001054 |
negative regulation of mesenchymal cell apoptotic process(GO:2001054) |
| 0.2 |
4.1 |
GO:0097201 |
negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.2 |
2.1 |
GO:1903715 |
regulation of aerobic respiration(GO:1903715) |
| 0.2 |
1.0 |
GO:0048861 |
leukemia inhibitory factor signaling pathway(GO:0048861) |
| 0.2 |
0.2 |
GO:0032765 |
positive regulation of mast cell cytokine production(GO:0032765) |
| 0.2 |
0.8 |
GO:1990502 |
dense core granule maturation(GO:1990502) |
| 0.2 |
0.4 |
GO:0038161 |
prolactin signaling pathway(GO:0038161) |
| 0.2 |
0.4 |
GO:0061535 |
glutamate secretion, neurotransmission(GO:0061535) |
| 0.2 |
0.6 |
GO:0030718 |
germ-line stem cell population maintenance(GO:0030718) |
| 0.2 |
1.8 |
GO:1904885 |
beta-catenin destruction complex assembly(GO:1904885) |
| 0.2 |
1.4 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.2 |
0.6 |
GO:0014050 |
negative regulation of glutamate secretion(GO:0014050) |
| 0.2 |
0.6 |
GO:0061055 |
myotome development(GO:0061055) |
| 0.2 |
0.8 |
GO:1902730 |
regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
| 0.2 |
0.4 |
GO:0032796 |
uropod organization(GO:0032796) |
| 0.2 |
1.4 |
GO:2000767 |
positive regulation of cytoplasmic translation(GO:2000767) |
| 0.2 |
1.2 |
GO:2000507 |
positive regulation of energy homeostasis(GO:2000507) |
| 0.2 |
0.6 |
GO:0021526 |
medial motor column neuron differentiation(GO:0021526) |
| 0.2 |
2.1 |
GO:2000467 |
positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.2 |
1.6 |
GO:0006741 |
NADP biosynthetic process(GO:0006741) |
| 0.2 |
2.9 |
GO:0035634 |
response to stilbenoid(GO:0035634) |
| 0.2 |
0.6 |
GO:2000417 |
negative regulation of eosinophil migration(GO:2000417) |
| 0.2 |
0.4 |
GO:0045362 |
regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
| 0.2 |
1.0 |
GO:0030047 |
actin modification(GO:0030047) |
| 0.2 |
1.9 |
GO:0031274 |
positive regulation of pseudopodium assembly(GO:0031274) |
| 0.2 |
0.2 |
GO:0071878 |
negative regulation of adrenergic receptor signaling pathway(GO:0071878) |
| 0.2 |
0.6 |
GO:1903452 |
regulation of G1 to G0 transition(GO:1903450) positive regulation of G1 to G0 transition(GO:1903452) |
| 0.2 |
0.9 |
GO:0072553 |
terminal button organization(GO:0072553) |
| 0.2 |
0.4 |
GO:0097267 |
omega-hydroxylase P450 pathway(GO:0097267) |
| 0.2 |
0.2 |
GO:0097051 |
establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
| 0.2 |
7.0 |
GO:0048246 |
macrophage chemotaxis(GO:0048246) |
| 0.2 |
1.9 |
GO:0034058 |
endosomal vesicle fusion(GO:0034058) |
| 0.2 |
0.9 |
GO:0019336 |
phenol-containing compound catabolic process(GO:0019336) |
| 0.2 |
0.2 |
GO:0031335 |
regulation of sulfur amino acid metabolic process(GO:0031335) regulation of homocysteine metabolic process(GO:0050666) |
| 0.2 |
4.8 |
GO:0007172 |
signal complex assembly(GO:0007172) |
| 0.2 |
0.7 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.2 |
0.9 |
GO:0010248 |
establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
| 0.2 |
0.7 |
GO:0048696 |
regulation of collateral sprouting in absence of injury(GO:0048696) negative regulation of collateral sprouting in absence of injury(GO:0048698) |
| 0.2 |
0.4 |
GO:1901727 |
positive regulation of histone deacetylase activity(GO:1901727) |
| 0.2 |
1.1 |
GO:0010793 |
regulation of mRNA export from nucleus(GO:0010793) |
| 0.2 |
1.7 |
GO:0060681 |
branch elongation involved in ureteric bud branching(GO:0060681) |
| 0.2 |
1.1 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.2 |
1.3 |
GO:0003199 |
endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 0.2 |
1.3 |
GO:0075525 |
viral translational termination-reinitiation(GO:0075525) |
| 0.2 |
1.8 |
GO:0034214 |
protein hexamerization(GO:0034214) |
| 0.2 |
0.7 |
GO:2000768 |
positive regulation of epithelial cell differentiation involved in kidney development(GO:2000698) positive regulation of nephron tubule epithelial cell differentiation(GO:2000768) |
| 0.2 |
0.5 |
GO:0035411 |
catenin import into nucleus(GO:0035411) |
| 0.2 |
0.5 |
GO:0006478 |
peptidyl-tyrosine sulfation(GO:0006478) |
| 0.2 |
3.7 |
GO:0046520 |
sphingoid biosynthetic process(GO:0046520) |
| 0.2 |
0.4 |
GO:0036353 |
histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.2 |
0.5 |
GO:0003245 |
cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.2 |
1.6 |
GO:0032510 |
endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.2 |
18.7 |
GO:2000649 |
regulation of sodium ion transmembrane transporter activity(GO:2000649) |
| 0.2 |
0.5 |
GO:0006065 |
UDP-glucuronate biosynthetic process(GO:0006065) |
| 0.2 |
1.4 |
GO:0032439 |
endosome localization(GO:0032439) |
| 0.2 |
2.3 |
GO:0042738 |
exogenous drug catabolic process(GO:0042738) |
| 0.2 |
0.4 |
GO:0007161 |
calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.2 |
3.0 |
GO:0009950 |
dorsal/ventral axis specification(GO:0009950) |
| 0.2 |
0.2 |
GO:2000410 |
regulation of thymocyte migration(GO:2000410) |
| 0.2 |
1.2 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.2 |
0.4 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.9 |
GO:0070777 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.2 |
0.7 |
GO:0090245 |
axis elongation involved in somitogenesis(GO:0090245) |
| 0.2 |
0.9 |
GO:0060120 |
auditory receptor cell fate commitment(GO:0009912) inner ear receptor cell fate commitment(GO:0060120) |
| 0.2 |
0.3 |
GO:2000276 |
negative regulation of oxidative phosphorylation uncoupler activity(GO:2000276) |
| 0.2 |
0.9 |
GO:0008204 |
ergosterol biosynthetic process(GO:0006696) ergosterol metabolic process(GO:0008204) |
| 0.2 |
0.9 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
1.7 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.2 |
1.0 |
GO:0034976 |
response to endoplasmic reticulum stress(GO:0034976) |
| 0.2 |
0.3 |
GO:0001923 |
B-1 B cell differentiation(GO:0001923) |
| 0.2 |
0.5 |
GO:0090118 |
receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.2 |
0.7 |
GO:0035188 |
blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
| 0.2 |
0.5 |
GO:0034146 |
toll-like receptor 5 signaling pathway(GO:0034146) |
| 0.2 |
0.5 |
GO:0043396 |
corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
| 0.2 |
1.4 |
GO:1903265 |
positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
| 0.2 |
1.2 |
GO:0046223 |
mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
| 0.2 |
0.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.2 |
1.5 |
GO:2001222 |
regulation of neuron migration(GO:2001222) |
| 0.2 |
1.2 |
GO:0070571 |
negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.2 |
0.5 |
GO:2000820 |
negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000820) |
| 0.2 |
3.8 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.2 |
0.8 |
GO:0044778 |
meiotic DNA integrity checkpoint(GO:0044778) |
| 0.2 |
0.5 |
GO:0021603 |
cranial nerve formation(GO:0021603) |
| 0.2 |
0.5 |
GO:1990519 |
pyrimidine nucleotide transport(GO:0006864) mitochondrial pyrimidine nucleotide import(GO:1990519) |
| 0.2 |
0.3 |
GO:0010716 |
negative regulation of extracellular matrix disassembly(GO:0010716) |
| 0.2 |
0.3 |
GO:1902309 |
negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
| 0.2 |
1.9 |
GO:0006657 |
CDP-choline pathway(GO:0006657) |
| 0.2 |
4.3 |
GO:0051639 |
actin filament network formation(GO:0051639) |
| 0.2 |
0.8 |
GO:0039019 |
pronephric nephron development(GO:0039019) |
| 0.2 |
0.2 |
GO:0035359 |
negative regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035359) |
| 0.2 |
0.6 |
GO:0060152 |
peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.2 |
0.5 |
GO:0038193 |
thromboxane A2 signaling pathway(GO:0038193) |
| 0.2 |
3.7 |
GO:0035458 |
cellular response to interferon-beta(GO:0035458) |
| 0.2 |
1.4 |
GO:0072733 |
response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.2 |
0.9 |
GO:0051121 |
hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
| 0.2 |
0.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.2 |
1.4 |
GO:0002175 |
protein localization to paranode region of axon(GO:0002175) |
| 0.2 |
0.5 |
GO:0002184 |
cytoplasmic translational termination(GO:0002184) |
| 0.2 |
0.6 |
GO:0042539 |
hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
| 0.2 |
6.9 |
GO:0007176 |
regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
| 0.2 |
0.9 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.2 |
1.4 |
GO:0018094 |
protein polyglycylation(GO:0018094) |
| 0.2 |
1.9 |
GO:1903608 |
protein localization to cytoplasmic stress granule(GO:1903608) |
| 0.2 |
1.7 |
GO:0006777 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
| 0.2 |
0.2 |
GO:0061052 |
negative regulation of cell growth involved in cardiac muscle cell development(GO:0061052) |
| 0.2 |
0.3 |
GO:0009153 |
purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.2 |
3.2 |
GO:0071850 |
mitotic cell cycle arrest(GO:0071850) |
| 0.2 |
0.6 |
GO:0032474 |
otolith morphogenesis(GO:0032474) |
| 0.2 |
0.2 |
GO:2001184 |
positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 |
1.5 |
GO:1901314 |
negative regulation of histone ubiquitination(GO:0033183) negative regulation of protein K63-linked ubiquitination(GO:1900045) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) negative regulation of protein polyubiquitination(GO:1902915) |
| 0.2 |
0.8 |
GO:0002317 |
plasma cell differentiation(GO:0002317) |
| 0.2 |
1.5 |
GO:0048386 |
positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
| 0.2 |
4.1 |
GO:0034389 |
lipid particle organization(GO:0034389) |
| 0.1 |
0.7 |
GO:0007288 |
sperm axoneme assembly(GO:0007288) |
| 0.1 |
1.3 |
GO:0006957 |
complement activation, alternative pathway(GO:0006957) |
| 0.1 |
0.9 |
GO:0043128 |
regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.1 |
0.6 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.1 |
0.6 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.1 |
0.6 |
GO:0009236 |
cobalamin biosynthetic process(GO:0009236) |
| 0.1 |
0.7 |
GO:0042360 |
vitamin E metabolic process(GO:0042360) |
| 0.1 |
0.4 |
GO:0097091 |
synaptic vesicle clustering(GO:0097091) |
| 0.1 |
0.4 |
GO:0002143 |
tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 |
2.3 |
GO:0033623 |
regulation of integrin activation(GO:0033623) |
| 0.1 |
1.3 |
GO:0035469 |
determination of pancreatic left/right asymmetry(GO:0035469) |
| 0.1 |
2.0 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
1.6 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.1 |
1.2 |
GO:1902856 |
negative regulation of nonmotile primary cilium assembly(GO:1902856) |
| 0.1 |
1.2 |
GO:0042780 |
tRNA 3'-end processing(GO:0042780) |
| 0.1 |
2.6 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
3.3 |
GO:0060213 |
regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
| 0.1 |
0.4 |
GO:0060285 |
cilium-dependent cell motility(GO:0060285) |
| 0.1 |
0.4 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.9 |
GO:0006438 |
valyl-tRNA aminoacylation(GO:0006438) |
| 0.1 |
1.1 |
GO:0003373 |
dynamin polymerization involved in membrane fission(GO:0003373) dynamin polymerization involved in mitochondrial fission(GO:0003374) |
| 0.1 |
0.1 |
GO:1903895 |
negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.1 |
0.1 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 |
0.4 |
GO:0006405 |
RNA export from nucleus(GO:0006405) |
| 0.1 |
1.0 |
GO:0070164 |
negative regulation of adiponectin secretion(GO:0070164) |
| 0.1 |
1.0 |
GO:0032468 |
Golgi calcium ion homeostasis(GO:0032468) |
| 0.1 |
0.4 |
GO:0034427 |
nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5'(GO:0034427) |
| 0.1 |
0.8 |
GO:0051547 |
regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
| 0.1 |
0.3 |
GO:1902174 |
positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.1 |
6.4 |
GO:0048488 |
synaptic vesicle endocytosis(GO:0048488) |
| 0.1 |
0.4 |
GO:0060180 |
female mating behavior(GO:0060180) |
| 0.1 |
0.1 |
GO:0048260 |
positive regulation of receptor-mediated endocytosis(GO:0048260) |
| 0.1 |
1.4 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.1 |
1.0 |
GO:0060244 |
negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
| 0.1 |
0.4 |
GO:1901842 |
negative regulation of high voltage-gated calcium channel activity(GO:1901842) |
| 0.1 |
0.4 |
GO:0042481 |
regulation of odontogenesis(GO:0042481) |
| 0.1 |
0.5 |
GO:1902683 |
regulation of receptor localization to synapse(GO:1902683) |
| 0.1 |
2.8 |
GO:0070977 |
bone maturation(GO:0070977) |
| 0.1 |
1.1 |
GO:0035093 |
spermatogenesis, exchange of chromosomal proteins(GO:0035093) |
| 0.1 |
0.8 |
GO:0090625 |
mRNA cleavage involved in gene silencing by siRNA(GO:0090625) |
| 0.1 |
0.7 |
GO:0002528 |
regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
| 0.1 |
0.9 |
GO:0015798 |
myo-inositol transport(GO:0015798) |
| 0.1 |
0.1 |
GO:0014005 |
microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.1 |
1.7 |
GO:0030213 |
hyaluronan biosynthetic process(GO:0030213) |
| 0.1 |
1.0 |
GO:0048227 |
plasma membrane to endosome transport(GO:0048227) |
| 0.1 |
0.4 |
GO:1904833 |
positive regulation of superoxide dismutase activity(GO:1901671) positive regulation of calcium-transporting ATPase activity(GO:1901896) negative regulation of DNA catabolic process(GO:1903625) positive regulation of removal of superoxide radicals(GO:1904833) |
| 0.1 |
1.4 |
GO:1904179 |
positive regulation of adipose tissue development(GO:1904179) |
| 0.1 |
2.1 |
GO:0036010 |
protein localization to endosome(GO:0036010) |
| 0.1 |
0.4 |
GO:0042418 |
epinephrine metabolic process(GO:0042414) epinephrine biosynthetic process(GO:0042418) |
| 0.1 |
0.4 |
GO:0003163 |
sinoatrial node development(GO:0003163) sinoatrial node cell differentiation(GO:0060921) sinoatrial node cell development(GO:0060931) |
| 0.1 |
0.3 |
GO:0035522 |
monoubiquitinated histone deubiquitination(GO:0035521) monoubiquitinated histone H2A deubiquitination(GO:0035522) |
| 0.1 |
0.9 |
GO:0051013 |
microtubule severing(GO:0051013) |
| 0.1 |
0.9 |
GO:0070120 |
ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
| 0.1 |
0.6 |
GO:0060022 |
hard palate development(GO:0060022) |
| 0.1 |
0.1 |
GO:1903936 |
response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
| 0.1 |
0.4 |
GO:0061300 |
cerebellum vasculature development(GO:0061300) |
| 0.1 |
0.1 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 |
1.3 |
GO:0060662 |
tube lumen cavitation(GO:0060605) salivary gland cavitation(GO:0060662) |
| 0.1 |
0.1 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.8 |
GO:2000825 |
positive regulation of androgen receptor activity(GO:2000825) |
| 0.1 |
0.9 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.1 |
3.9 |
GO:0090162 |
establishment of epithelial cell polarity(GO:0090162) |
| 0.1 |
1.1 |
GO:0085020 |
protein K6-linked ubiquitination(GO:0085020) |
| 0.1 |
0.4 |
GO:0021889 |
olfactory bulb interneuron differentiation(GO:0021889) |
| 0.1 |
1.7 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 |
0.6 |
GO:0015014 |
heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
| 0.1 |
0.4 |
GO:0002416 |
IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor(GO:0002416) |
| 0.1 |
0.4 |
GO:0035508 |
positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
| 0.1 |
0.8 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.1 |
0.4 |
GO:0019262 |
N-acetylneuraminate catabolic process(GO:0019262) |
| 0.1 |
0.5 |
GO:1903381 |
neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0036483) regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903381) negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903382) |
| 0.1 |
6.0 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.1 |
1.1 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
4.7 |
GO:1901687 |
glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
| 0.1 |
0.7 |
GO:2000504 |
positive regulation of blood vessel remodeling(GO:2000504) |
| 0.1 |
0.8 |
GO:0021988 |
olfactory lobe development(GO:0021988) |
| 0.1 |
0.7 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.1 |
0.7 |
GO:2001106 |
regulation of Rho guanyl-nucleotide exchange factor activity(GO:2001106) |
| 0.1 |
1.7 |
GO:0051451 |
myoblast migration(GO:0051451) |
| 0.1 |
0.2 |
GO:0006579 |
amino-acid betaine catabolic process(GO:0006579) |
| 0.1 |
2.6 |
GO:2000811 |
negative regulation of anoikis(GO:2000811) |
| 0.1 |
1.8 |
GO:0016540 |
protein autoprocessing(GO:0016540) |
| 0.1 |
0.5 |
GO:0090094 |
metanephric cap development(GO:0072185) metanephric cap morphogenesis(GO:0072186) metanephric cap mesenchymal cell proliferation involved in metanephros development(GO:0090094) regulation of metanephric cap mesenchymal cell proliferation(GO:0090095) positive regulation of metanephric cap mesenchymal cell proliferation(GO:0090096) |
| 0.1 |
0.4 |
GO:0071930 |
negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.1 |
0.2 |
GO:0035655 |
interleukin-18-mediated signaling pathway(GO:0035655) cellular response to interleukin-18(GO:0071351) |
| 0.1 |
0.5 |
GO:0007341 |
penetration of zona pellucida(GO:0007341) |
| 0.1 |
0.1 |
GO:0015870 |
acetylcholine transport(GO:0015870) acetate ester transport(GO:1901374) |
| 0.1 |
6.8 |
GO:0000413 |
protein peptidyl-prolyl isomerization(GO:0000413) |
| 0.1 |
1.2 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
1.9 |
GO:0032968 |
positive regulation of transcription elongation from RNA polymerase II promoter(GO:0032968) |
| 0.1 |
3.1 |
GO:0098915 |
membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
| 0.1 |
0.1 |
GO:2000643 |
positive regulation of early endosome to late endosome transport(GO:2000643) |
| 0.1 |
0.3 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.3 |
GO:0002265 |
astrocyte activation involved in immune response(GO:0002265) |
| 0.1 |
0.3 |
GO:0002763 |
positive regulation of myeloid leukocyte differentiation(GO:0002763) |
| 0.1 |
0.8 |
GO:0060075 |
regulation of resting membrane potential(GO:0060075) |
| 0.1 |
2.6 |
GO:1902236 |
negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
| 0.1 |
0.8 |
GO:0032252 |
secretory granule localization(GO:0032252) |
| 0.1 |
1.2 |
GO:0007042 |
lysosomal lumen acidification(GO:0007042) |
| 0.1 |
1.7 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.1 |
2.2 |
GO:0009313 |
oligosaccharide catabolic process(GO:0009313) |
| 0.1 |
0.3 |
GO:0003095 |
pressure natriuresis(GO:0003095) |
| 0.1 |
1.2 |
GO:2000680 |
rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
| 0.1 |
0.2 |
GO:0097476 |
spinal cord motor neuron migration(GO:0097476) lateral motor column neuron migration(GO:0097477) |
| 0.1 |
0.2 |
GO:2000628 |
regulation of miRNA metabolic process(GO:2000628) |
| 0.1 |
1.5 |
GO:1901838 |
positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
| 0.1 |
0.1 |
GO:0032480 |
negative regulation of type I interferon production(GO:0032480) |
| 0.1 |
0.9 |
GO:0034384 |
high-density lipoprotein particle clearance(GO:0034384) |
| 0.1 |
0.3 |
GO:0035814 |
negative regulation of renal sodium excretion(GO:0035814) |
| 0.1 |
0.5 |
GO:0002378 |
immunoglobulin biosynthetic process(GO:0002378) |
| 0.1 |
0.3 |
GO:0038194 |
thyroid-stimulating hormone signaling pathway(GO:0038194) cellular response to glycoprotein(GO:1904588) cellular response to thyrotropin-releasing hormone(GO:1905229) |
| 0.1 |
0.4 |
GO:0033084 |
regulation of immature T cell proliferation in thymus(GO:0033084) negative regulation of immature T cell proliferation in thymus(GO:0033088) |
| 0.1 |
0.4 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.1 |
0.1 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
1.0 |
GO:0010265 |
SCF complex assembly(GO:0010265) |
| 0.1 |
0.4 |
GO:0042430 |
indolalkylamine metabolic process(GO:0006586) indole-containing compound metabolic process(GO:0042430) |
| 0.1 |
5.9 |
GO:0070911 |
global genome nucleotide-excision repair(GO:0070911) |
| 0.1 |
0.4 |
GO:0006617 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
| 0.1 |
0.2 |
GO:0035811 |
negative regulation of urine volume(GO:0035811) |
| 0.1 |
0.5 |
GO:0002296 |
T-helper 1 cell lineage commitment(GO:0002296) |
| 0.1 |
0.3 |
GO:0060629 |
meiotic DNA double-strand break formation(GO:0042138) regulation of homologous chromosome segregation(GO:0060629) |
| 0.1 |
0.2 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.1 |
1.6 |
GO:0071404 |
cellular response to low-density lipoprotein particle stimulus(GO:0071404) |
| 0.1 |
0.5 |
GO:2000505 |
regulation of energy homeostasis(GO:2000505) |
| 0.1 |
0.1 |
GO:0019240 |
citrulline biosynthetic process(GO:0019240) |
| 0.1 |
1.4 |
GO:1900025 |
negative regulation of substrate adhesion-dependent cell spreading(GO:1900025) |
| 0.1 |
0.6 |
GO:0061083 |
regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
| 0.1 |
0.3 |
GO:0039533 |
regulation of MDA-5 signaling pathway(GO:0039533) |
| 0.1 |
3.4 |
GO:0016338 |
calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
| 0.1 |
1.4 |
GO:0010818 |
T cell chemotaxis(GO:0010818) |
| 0.1 |
0.1 |
GO:0060623 |
regulation of chromosome condensation(GO:0060623) |
| 0.1 |
0.4 |
GO:0097084 |
vascular smooth muscle cell development(GO:0097084) |
| 0.1 |
7.0 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.1 |
0.5 |
GO:0048733 |
sebaceous gland development(GO:0048733) |
| 0.1 |
1.2 |
GO:0006294 |
nucleotide-excision repair, preincision complex assembly(GO:0006294) |
| 0.1 |
3.1 |
GO:0072673 |
lamellipodium morphogenesis(GO:0072673) |
| 0.1 |
0.1 |
GO:0035999 |
tetrahydrofolate interconversion(GO:0035999) |
| 0.1 |
0.5 |
GO:1903593 |
regulation of histamine secretion by mast cell(GO:1903593) |
| 0.1 |
0.3 |
GO:1904211 |
membrane protein proteolysis involved in retrograde protein transport, ER to cytosol(GO:1904211) |
| 0.1 |
1.0 |
GO:0016322 |
neuron remodeling(GO:0016322) |
| 0.1 |
0.2 |
GO:1902563 |
regulation of neutrophil activation(GO:1902563) |
| 0.1 |
2.2 |
GO:0071985 |
multivesicular body sorting pathway(GO:0071985) |
| 0.1 |
0.4 |
GO:0097205 |
glomerular filtration(GO:0003094) renal filtration(GO:0097205) |
| 0.1 |
0.8 |
GO:0070537 |
histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 |
0.4 |
GO:1903236 |
regulation of leukocyte tethering or rolling(GO:1903236) negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.1 |
2.5 |
GO:0014059 |
dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
| 0.1 |
0.6 |
GO:0055011 |
atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
| 0.1 |
0.9 |
GO:0030854 |
positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 |
0.4 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.1 |
0.3 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
0.4 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.4 |
GO:0034334 |
adherens junction maintenance(GO:0034334) |
| 0.1 |
1.1 |
GO:0070257 |
positive regulation of mucus secretion(GO:0070257) |
| 0.1 |
0.3 |
GO:0043932 |
ossification involved in bone remodeling(GO:0043932) |
| 0.1 |
1.5 |
GO:1904262 |
negative regulation of TORC1 signaling(GO:1904262) |
| 0.1 |
1.0 |
GO:0000389 |
mRNA 3'-splice site recognition(GO:0000389) |
| 0.1 |
0.4 |
GO:0031639 |
plasminogen activation(GO:0031639) |
| 0.1 |
0.4 |
GO:1902963 |
regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902962) negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902963) |
| 0.1 |
0.5 |
GO:0001315 |
age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
| 0.1 |
6.6 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.1 |
1.9 |
GO:0002710 |
negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 |
0.1 |
GO:0030889 |
negative regulation of B cell proliferation(GO:0030889) |
| 0.1 |
5.4 |
GO:0021762 |
substantia nigra development(GO:0021762) |
| 0.1 |
0.8 |
GO:0010606 |
positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
| 0.1 |
0.5 |
GO:0072429 |
response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.1 |
0.2 |
GO:0086068 |
Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
| 0.1 |
0.5 |
GO:2000048 |
negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
| 0.1 |
0.2 |
GO:0070253 |
somatostatin secretion(GO:0070253) |
| 0.1 |
1.3 |
GO:0070863 |
positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
| 0.1 |
0.1 |
GO:0021897 |
forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.1 |
1.7 |
GO:0045662 |
negative regulation of myoblast differentiation(GO:0045662) |
| 0.1 |
1.0 |
GO:1901407 |
regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901407) |
| 0.1 |
2.5 |
GO:0060561 |
apoptotic process involved in morphogenesis(GO:0060561) |
| 0.1 |
0.5 |
GO:0048820 |
hair follicle maturation(GO:0048820) |
| 0.1 |
0.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.1 |
0.7 |
GO:0090220 |
chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
| 0.1 |
0.3 |
GO:2001013 |
epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
| 0.1 |
1.6 |
GO:0060219 |
camera-type eye photoreceptor cell differentiation(GO:0060219) |
| 0.1 |
0.3 |
GO:0014824 |
artery smooth muscle contraction(GO:0014824) |
| 0.1 |
0.7 |
GO:0032482 |
Rab protein signal transduction(GO:0032482) |
| 0.1 |
0.4 |
GO:0010835 |
regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 |
0.3 |
GO:0003339 |
regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
| 0.1 |
0.8 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.1 |
GO:0032025 |
response to cobalt ion(GO:0032025) |
| 0.1 |
0.3 |
GO:0048254 |
snoRNA localization(GO:0048254) |
| 0.1 |
0.3 |
GO:1904252 |
negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.1 |
0.9 |
GO:0050942 |
positive regulation of pigment cell differentiation(GO:0050942) |
| 0.1 |
0.5 |
GO:0016480 |
negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.1 |
1.4 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.1 |
0.6 |
GO:0097062 |
dendritic spine maintenance(GO:0097062) |
| 0.1 |
1.1 |
GO:0010765 |
positive regulation of sodium ion transport(GO:0010765) |
| 0.1 |
7.3 |
GO:0042035 |
regulation of cytokine biosynthetic process(GO:0042035) |
| 0.1 |
0.5 |
GO:0046469 |
platelet activating factor metabolic process(GO:0046469) |
| 0.1 |
0.4 |
GO:0070973 |
protein localization to endoplasmic reticulum exit site(GO:0070973) |
| 0.1 |
0.2 |
GO:2000035 |
regulation of stem cell division(GO:2000035) |
| 0.1 |
0.3 |
GO:0016094 |
polyprenol biosynthetic process(GO:0016094) |
| 0.1 |
0.3 |
GO:1901475 |
pyruvate transport(GO:0006848) pyruvate transmembrane transport(GO:1901475) |
| 0.1 |
0.7 |
GO:0017062 |
respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
| 0.1 |
1.1 |
GO:0021957 |
corticospinal tract morphogenesis(GO:0021957) |
| 0.1 |
0.2 |
GO:0035246 |
peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
| 0.1 |
0.3 |
GO:0042351 |
'de novo' GDP-L-fucose biosynthetic process(GO:0042351) |
| 0.1 |
0.2 |
GO:0035106 |
operant conditioning(GO:0035106) |
| 0.1 |
0.7 |
GO:0007621 |
negative regulation of female receptivity(GO:0007621) |
| 0.1 |
0.6 |
GO:0031640 |
killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
| 0.1 |
0.2 |
GO:1903527 |
positive regulation of membrane tubulation(GO:1903527) |
| 0.1 |
0.3 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.1 |
0.2 |
GO:0006620 |
posttranslational protein targeting to membrane(GO:0006620) |
| 0.1 |
0.2 |
GO:0050894 |
determination of affect(GO:0050894) |
| 0.1 |
0.4 |
GO:0045721 |
negative regulation of gluconeogenesis(GO:0045721) |
| 0.1 |
1.9 |
GO:0044872 |
lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 |
0.5 |
GO:0001705 |
ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
| 0.1 |
1.7 |
GO:0061099 |
negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 |
0.2 |
GO:0044789 |
modulation by host of viral release from host cell(GO:0044789) positive regulation by host of viral release from host cell(GO:0044791) |
| 0.1 |
1.1 |
GO:0090161 |
Golgi ribbon formation(GO:0090161) |
| 0.1 |
0.2 |
GO:0051037 |
regulation of transcription involved in meiotic cell cycle(GO:0051037) |
| 0.1 |
0.3 |
GO:0036337 |
Fas signaling pathway(GO:0036337) |
| 0.1 |
0.5 |
GO:0008063 |
Toll signaling pathway(GO:0008063) |
| 0.1 |
1.1 |
GO:2000587 |
negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
| 0.1 |
0.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.1 |
0.4 |
GO:0038145 |
macrophage colony-stimulating factor signaling pathway(GO:0038145) |
| 0.1 |
0.2 |
GO:0034650 |
aldosterone metabolic process(GO:0032341) aldosterone biosynthetic process(GO:0032342) cortisol metabolic process(GO:0034650) cortisol biosynthetic process(GO:0034651) response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
| 0.1 |
0.2 |
GO:0044026 |
DNA hypermethylation(GO:0044026) |
| 0.1 |
0.6 |
GO:0071803 |
positive regulation of podosome assembly(GO:0071803) |
| 0.1 |
0.1 |
GO:0097695 |
establishment of RNA localization to telomere(GO:0097694) establishment of macromolecular complex localization to telomere(GO:0097695) telomerase catalytic core complex assembly(GO:1904868) regulation of telomerase catalytic core complex assembly(GO:1904882) positive regulation of telomerase catalytic core complex assembly(GO:1904884) |
| 0.1 |
0.8 |
GO:0015747 |
urate transport(GO:0015747) |
| 0.1 |
3.6 |
GO:0030835 |
negative regulation of actin filament depolymerization(GO:0030835) |
| 0.1 |
0.3 |
GO:0044339 |
canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.1 |
0.8 |
GO:0070932 |
histone H3 deacetylation(GO:0070932) |
| 0.1 |
2.0 |
GO:0043090 |
amino acid import(GO:0043090) |
| 0.1 |
0.4 |
GO:0030581 |
intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
| 0.1 |
0.4 |
GO:0071971 |
extracellular exosome assembly(GO:0071971) |
| 0.1 |
5.2 |
GO:0003341 |
cilium movement(GO:0003341) |
| 0.1 |
1.0 |
GO:2000675 |
negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.1 |
0.4 |
GO:0039536 |
negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 |
0.1 |
GO:0042335 |
cuticle development(GO:0042335) |
| 0.1 |
0.9 |
GO:0038180 |
nerve growth factor signaling pathway(GO:0038180) |
| 0.1 |
0.3 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.1 |
0.2 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.1 |
0.2 |
GO:0002643 |
regulation of tolerance induction(GO:0002643) |
| 0.1 |
0.1 |
GO:0015803 |
branched-chain amino acid transport(GO:0015803) |
| 0.1 |
0.5 |
GO:0046604 |
positive regulation of mitotic centrosome separation(GO:0046604) |
| 0.1 |
0.4 |
GO:1903070 |
negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.1 |
0.2 |
GO:0000350 |
generation of catalytic spliceosome for second transesterification step(GO:0000350) positive regulation of response to alcohol(GO:1901421) |
| 0.1 |
2.0 |
GO:0007216 |
G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
| 0.1 |
0.9 |
GO:0048280 |
vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.1 |
1.0 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.1 |
0.7 |
GO:0015812 |
gamma-aminobutyric acid transport(GO:0015812) |
| 0.1 |
2.8 |
GO:0000289 |
nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
| 0.1 |
0.5 |
GO:0010614 |
negative regulation of cardiac muscle hypertrophy(GO:0010614) negative regulation of muscle hypertrophy(GO:0014741) |
| 0.1 |
0.3 |
GO:0090283 |
regulation of protein glycosylation in Golgi(GO:0090283) |
| 0.1 |
0.2 |
GO:0019627 |
urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.1 |
0.1 |
GO:1903297 |
regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) intrinsic apoptotic signaling pathway in response to hypoxia(GO:1990144) |
| 0.1 |
1.3 |
GO:0007084 |
mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 |
0.2 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
| 0.1 |
0.3 |
GO:1903445 |
intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 |
0.2 |
GO:0018963 |
insecticide metabolic process(GO:0017143) dibenzo-p-dioxin metabolic process(GO:0018894) phthalate metabolic process(GO:0018963) |
| 0.1 |
1.0 |
GO:0071243 |
cellular response to arsenic-containing substance(GO:0071243) |
| 0.1 |
0.8 |
GO:1900112 |
regulation of histone H3-K9 trimethylation(GO:1900112) |
| 0.1 |
0.1 |
GO:0010966 |
regulation of phosphate transport(GO:0010966) |
| 0.1 |
0.3 |
GO:0050992 |
dimethylallyl diphosphate biosynthetic process(GO:0050992) dimethylallyl diphosphate metabolic process(GO:0050993) |
| 0.1 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 0.1 |
0.3 |
GO:0044030 |
regulation of DNA methylation(GO:0044030) |
| 0.1 |
0.6 |
GO:0035494 |
SNARE complex disassembly(GO:0035494) |
| 0.1 |
0.6 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.1 |
1.7 |
GO:0061003 |
positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.1 |
1.2 |
GO:0031293 |
membrane protein intracellular domain proteolysis(GO:0031293) |
| 0.1 |
0.2 |
GO:0015993 |
molecular hydrogen transport(GO:0015993) |
| 0.1 |
2.0 |
GO:0070534 |
protein K63-linked ubiquitination(GO:0070534) |
| 0.1 |
0.3 |
GO:0071344 |
diphosphate metabolic process(GO:0071344) |
| 0.1 |
1.1 |
GO:0035067 |
negative regulation of histone acetylation(GO:0035067) |
| 0.1 |
0.3 |
GO:0048243 |
norepinephrine secretion(GO:0048243) |
| 0.1 |
0.1 |
GO:0006473 |
protein acetylation(GO:0006473) |
| 0.1 |
0.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.1 |
0.9 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.1 |
0.3 |
GO:0090669 |
telomerase RNA stabilization(GO:0090669) |
| 0.1 |
0.1 |
GO:0010360 |
negative regulation of anion channel activity(GO:0010360) |
| 0.1 |
0.2 |
GO:0035672 |
oligopeptide transmembrane transport(GO:0035672) |
| 0.1 |
0.2 |
GO:0071460 |
cellular response to cell-matrix adhesion(GO:0071460) |
| 0.1 |
0.5 |
GO:0010891 |
negative regulation of sequestering of triglyceride(GO:0010891) |
| 0.1 |
0.1 |
GO:0044029 |
DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
| 0.1 |
0.5 |
GO:0030038 |
contractile actin filament bundle assembly(GO:0030038) stress fiber assembly(GO:0043149) |
| 0.1 |
0.8 |
GO:0071481 |
cellular response to X-ray(GO:0071481) |
| 0.1 |
0.1 |
GO:0060137 |
maternal process involved in parturition(GO:0060137) |
| 0.1 |
0.8 |
GO:0033197 |
response to vitamin E(GO:0033197) |
| 0.1 |
1.2 |
GO:1900027 |
regulation of ruffle assembly(GO:1900027) |
| 0.1 |
1.2 |
GO:0000244 |
spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 |
1.9 |
GO:0035728 |
response to hepatocyte growth factor(GO:0035728) |
| 0.1 |
1.0 |
GO:0001829 |
trophectodermal cell differentiation(GO:0001829) |
| 0.1 |
0.8 |
GO:0072189 |
ureter development(GO:0072189) |
| 0.1 |
0.3 |
GO:0044210 |
'de novo' CTP biosynthetic process(GO:0044210) |
| 0.1 |
0.4 |
GO:0051697 |
protein delipidation(GO:0051697) |
| 0.1 |
0.1 |
GO:0008078 |
mesodermal cell migration(GO:0008078) |
| 0.1 |
0.9 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 |
1.1 |
GO:0034975 |
protein folding in endoplasmic reticulum(GO:0034975) |
| 0.1 |
0.6 |
GO:0033211 |
adiponectin-activated signaling pathway(GO:0033211) |
| 0.1 |
0.4 |
GO:0038195 |
urokinase plasminogen activator signaling pathway(GO:0038195) |
| 0.1 |
0.7 |
GO:0034380 |
high-density lipoprotein particle assembly(GO:0034380) |
| 0.1 |
0.6 |
GO:0006509 |
membrane protein ectodomain proteolysis(GO:0006509) |
| 0.1 |
0.6 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.1 |
0.5 |
GO:0060125 |
negative regulation of growth hormone secretion(GO:0060125) |
| 0.1 |
0.2 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
| 0.1 |
0.5 |
GO:0090646 |
mitochondrial tRNA processing(GO:0090646) |
| 0.1 |
1.4 |
GO:0006068 |
ethanol catabolic process(GO:0006068) |
| 0.1 |
1.4 |
GO:0006972 |
hyperosmotic response(GO:0006972) |
| 0.1 |
1.8 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.3 |
GO:0007181 |
transforming growth factor beta receptor complex assembly(GO:0007181) |
| 0.1 |
2.2 |
GO:0071300 |
cellular response to retinoic acid(GO:0071300) |
| 0.1 |
0.9 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.1 |
0.2 |
GO:0035878 |
nail development(GO:0035878) |
| 0.1 |
0.2 |
GO:0035721 |
intraciliary retrograde transport(GO:0035721) |
| 0.1 |
0.5 |
GO:0032782 |
bile acid secretion(GO:0032782) |
| 0.1 |
1.8 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.1 |
0.2 |
GO:0006597 |
spermine biosynthetic process(GO:0006597) |
| 0.1 |
0.8 |
GO:0014877 |
response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
| 0.1 |
0.1 |
GO:0071941 |
nitrogen cycle metabolic process(GO:0071941) |
| 0.1 |
1.0 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.3 |
GO:0006121 |
mitochondrial electron transport, succinate to ubiquinone(GO:0006121) |
| 0.1 |
0.5 |
GO:0006003 |
fructose 2,6-bisphosphate metabolic process(GO:0006003) |
| 0.1 |
3.4 |
GO:0048207 |
vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.1 |
0.1 |
GO:0016098 |
monoterpenoid metabolic process(GO:0016098) |
| 0.1 |
1.7 |
GO:1902857 |
positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.1 |
1.2 |
GO:0008213 |
protein methylation(GO:0006479) protein alkylation(GO:0008213) |
| 0.1 |
1.4 |
GO:0035459 |
cargo loading into vesicle(GO:0035459) |
| 0.1 |
1.3 |
GO:2000052 |
positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
| 0.1 |
1.2 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.2 |
GO:0046338 |
phosphatidylethanolamine catabolic process(GO:0046338) |
| 0.1 |
0.1 |
GO:0032648 |
interferon-beta production(GO:0032608) regulation of interferon-beta production(GO:0032648) |
| 0.1 |
0.6 |
GO:2001224 |
positive regulation of neuron migration(GO:2001224) |
| 0.1 |
0.1 |
GO:0002351 |
serotonin production involved in inflammatory response(GO:0002351) serotonin secretion involved in inflammatory response(GO:0002442) serotonin secretion by platelet(GO:0002554) |
| 0.1 |
0.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.1 |
0.3 |
GO:0001656 |
metanephros development(GO:0001656) |
| 0.1 |
0.2 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.1 |
0.4 |
GO:0090155 |
negative regulation of sphingolipid biosynthetic process(GO:0090155) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 |
0.5 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.1 |
1.7 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.1 |
0.2 |
GO:0090286 |
cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.1 |
0.2 |
GO:0035349 |
coenzyme A transport(GO:0015880) coenzyme A transmembrane transport(GO:0035349) adenosine 3',5'-bisphosphate transmembrane transport(GO:0071106) AMP transport(GO:0080121) |
| 0.1 |
0.3 |
GO:0006651 |
diacylglycerol biosynthetic process(GO:0006651) |
| 0.1 |
0.2 |
GO:0070350 |
white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
| 0.1 |
0.4 |
GO:0010666 |
positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
| 0.1 |
0.2 |
GO:0006102 |
isocitrate metabolic process(GO:0006102) |
| 0.1 |
0.2 |
GO:0008616 |
queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
| 0.1 |
0.1 |
GO:0002904 |
positive regulation of B cell apoptotic process(GO:0002904) |
| 0.1 |
0.6 |
GO:0097320 |
membrane tubulation(GO:0097320) |
| 0.1 |
0.3 |
GO:0070914 |
UV-damage excision repair(GO:0070914) |
| 0.1 |
0.7 |
GO:0071763 |
nuclear membrane organization(GO:0071763) |
| 0.1 |
0.3 |
GO:0035726 |
common myeloid progenitor cell proliferation(GO:0035726) |
| 0.1 |
0.2 |
GO:0046041 |
ITP metabolic process(GO:0046041) |
| 0.1 |
0.1 |
GO:0072679 |
thymocyte migration(GO:0072679) |
| 0.1 |
0.2 |
GO:0034184 |
positive regulation of maintenance of sister chromatid cohesion(GO:0034093) positive regulation of maintenance of mitotic sister chromatid cohesion(GO:0034184) |
| 0.1 |
0.6 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.1 |
0.1 |
GO:0002188 |
translation reinitiation(GO:0002188) |
| 0.1 |
0.6 |
GO:0051791 |
medium-chain fatty acid metabolic process(GO:0051791) |
| 0.1 |
0.3 |
GO:0033159 |
negative regulation of protein import into nucleus, translocation(GO:0033159) |
| 0.1 |
0.1 |
GO:0045348 |
positive regulation of MHC class II biosynthetic process(GO:0045348) |
| 0.1 |
0.3 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.1 |
0.9 |
GO:0097067 |
cellular response to thyroid hormone stimulus(GO:0097067) |
| 0.1 |
0.3 |
GO:2000312 |
regulation of kainate selective glutamate receptor activity(GO:2000312) |
| 0.1 |
0.3 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.1 |
0.3 |
GO:0032456 |
endocytic recycling(GO:0032456) |
| 0.1 |
0.3 |
GO:0022011 |
Schwann cell development(GO:0014044) myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.1 |
0.2 |
GO:0043435 |
response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
| 0.1 |
0.2 |
GO:0061484 |
hematopoietic stem cell homeostasis(GO:0061484) |
| 0.1 |
3.6 |
GO:0097581 |
lamellipodium organization(GO:0097581) |
| 0.1 |
0.4 |
GO:0031087 |
deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.0 |
1.1 |
GO:0045116 |
protein neddylation(GO:0045116) |
| 0.0 |
0.9 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.2 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.0 |
1.5 |
GO:0048025 |
negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
| 0.0 |
0.5 |
GO:0072488 |
ammonium transmembrane transport(GO:0072488) |
| 0.0 |
0.2 |
GO:0001514 |
selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.0 |
0.2 |
GO:0038169 |
somatostatin receptor signaling pathway(GO:0038169) somatostatin signaling pathway(GO:0038170) |
| 0.0 |
0.4 |
GO:1904220 |
regulation of serine C-palmitoyltransferase activity(GO:1904220) |
| 0.0 |
1.5 |
GO:0000301 |
retrograde transport, vesicle recycling within Golgi(GO:0000301) |
| 0.0 |
0.7 |
GO:0030388 |
fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.0 |
1.6 |
GO:0048599 |
oocyte development(GO:0048599) |
| 0.0 |
0.1 |
GO:0060385 |
axonogenesis involved in innervation(GO:0060385) |
| 0.0 |
0.3 |
GO:0071625 |
vocalization behavior(GO:0071625) |
| 0.0 |
0.2 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.0 |
0.4 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.1 |
GO:0051138 |
positive regulation of NK T cell differentiation(GO:0051138) |
| 0.0 |
0.3 |
GO:0042117 |
monocyte activation(GO:0042117) |
| 0.0 |
0.1 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.0 |
0.5 |
GO:0045040 |
protein import into mitochondrial outer membrane(GO:0045040) |
| 0.0 |
0.3 |
GO:0035092 |
sperm chromatin condensation(GO:0035092) |
| 0.0 |
0.4 |
GO:0072511 |
divalent metal ion transport(GO:0070838) divalent inorganic cation transport(GO:0072511) |
| 0.0 |
0.2 |
GO:1901739 |
regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
| 0.0 |
0.1 |
GO:0019626 |
short-chain fatty acid catabolic process(GO:0019626) |
| 0.0 |
2.8 |
GO:0006120 |
mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
| 0.0 |
0.3 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) |
| 0.0 |
0.1 |
GO:0007096 |
regulation of exit from mitosis(GO:0007096) |
| 0.0 |
0.3 |
GO:0032525 |
somite rostral/caudal axis specification(GO:0032525) |
| 0.0 |
0.5 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.0 |
0.2 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.0 |
0.3 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) negative regulation of cardiac muscle contraction(GO:0055118) |
| 0.0 |
0.7 |
GO:0006069 |
ethanol oxidation(GO:0006069) |
| 0.0 |
0.2 |
GO:0090287 |
regulation of cellular response to growth factor stimulus(GO:0090287) |
| 0.0 |
0.1 |
GO:0045897 |
regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.0 |
3.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
1.7 |
GO:1900740 |
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
| 0.0 |
0.8 |
GO:0033539 |
fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
| 0.0 |
0.7 |
GO:0019511 |
peptidyl-proline hydroxylation(GO:0019511) |
| 0.0 |
4.0 |
GO:0006501 |
C-terminal protein lipidation(GO:0006501) |
| 0.0 |
0.2 |
GO:0044111 |
multi-organism catabolic process(GO:0044035) development involved in symbiotic interaction(GO:0044111) development of symbiont involved in interaction with host(GO:0044115) modulation of development of symbiont involved in interaction with host(GO:0044145) negative regulation of development of symbiont involved in interaction with host(GO:0044147) metabolism of substance in other organism involved in symbiotic interaction(GO:0052214) catabolism of substance in other organism involved in symbiotic interaction(GO:0052227) metabolism of macromolecule in other organism involved in symbiotic interaction(GO:0052229) catabolism by host of symbiont macromolecule(GO:0052360) catabolism by organism of macromolecule in other organism involved in symbiotic interaction(GO:0052361) catabolism by host of symbiont protein(GO:0052362) catabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052363) catabolism by host of substance in symbiont(GO:0052364) metabolism by host of symbiont macromolecule(GO:0052416) metabolism by host of symbiont protein(GO:0052417) metabolism by organism of protein in other organism involved in symbiotic interaction(GO:0052418) metabolism by host of substance in symbiont(GO:0052419) |
| 0.0 |
0.2 |
GO:0043619 |
regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
| 0.0 |
0.1 |
GO:2000286 |
receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
| 0.0 |
0.5 |
GO:0035635 |
entry of bacterium into host cell(GO:0035635) |
| 0.0 |
0.1 |
GO:0002361 |
CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0002361) |
| 0.0 |
0.2 |
GO:0006789 |
bilirubin conjugation(GO:0006789) |
| 0.0 |
3.5 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.0 |
2.0 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
1.8 |
GO:0034103 |
regulation of tissue remodeling(GO:0034103) |
| 0.0 |
0.8 |
GO:0036315 |
cellular response to sterol(GO:0036315) |
| 0.0 |
0.1 |
GO:0035234 |
ectopic germ cell programmed cell death(GO:0035234) |
| 0.0 |
0.5 |
GO:0061436 |
regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
| 0.0 |
0.3 |
GO:1902415 |
regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
| 0.0 |
0.8 |
GO:0000470 |
maturation of LSU-rRNA(GO:0000470) |
| 0.0 |
0.3 |
GO:0033314 |
mitotic DNA replication checkpoint(GO:0033314) |
| 0.0 |
0.6 |
GO:0070262 |
peptidyl-serine dephosphorylation(GO:0070262) |
| 0.0 |
0.1 |
GO:1901053 |
sarcosine metabolic process(GO:1901052) sarcosine catabolic process(GO:1901053) |
| 0.0 |
0.4 |
GO:0042136 |
neurotransmitter biosynthetic process(GO:0042136) |
| 0.0 |
0.5 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.0 |
0.3 |
GO:0050713 |
negative regulation of interleukin-1 beta secretion(GO:0050713) |
| 0.0 |
0.3 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
0.7 |
GO:0006783 |
heme biosynthetic process(GO:0006783) |
| 0.0 |
0.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.0 |
0.6 |
GO:0061157 |
mRNA destabilization(GO:0061157) |
| 0.0 |
0.1 |
GO:0060745 |
mammary gland branching involved in pregnancy(GO:0060745) |
| 0.0 |
0.1 |
GO:0060484 |
lung-associated mesenchyme development(GO:0060484) |
| 0.0 |
0.3 |
GO:0033234 |
negative regulation of protein sumoylation(GO:0033234) |
| 0.0 |
0.4 |
GO:0007258 |
JUN phosphorylation(GO:0007258) |
| 0.0 |
0.9 |
GO:0006471 |
protein ADP-ribosylation(GO:0006471) |
| 0.0 |
0.1 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
0.1 |
GO:0030886 |
negative regulation of myeloid dendritic cell activation(GO:0030886) |
| 0.0 |
1.0 |
GO:0006891 |
intra-Golgi vesicle-mediated transport(GO:0006891) |
| 0.0 |
0.2 |
GO:0070940 |
dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.0 |
1.0 |
GO:0032958 |
inositol phosphate biosynthetic process(GO:0032958) |
| 0.0 |
0.4 |
GO:0010032 |
meiotic chromosome condensation(GO:0010032) |
| 0.0 |
0.2 |
GO:0090070 |
positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.0 |
0.1 |
GO:0042256 |
mature ribosome assembly(GO:0042256) |
| 0.0 |
0.5 |
GO:0035360 |
positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.0 |
0.7 |
GO:0050962 |
detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
| 0.0 |
0.1 |
GO:0097010 |
eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
| 0.0 |
0.7 |
GO:0097435 |
fibril organization(GO:0097435) |
| 0.0 |
1.0 |
GO:0022400 |
regulation of rhodopsin mediated signaling pathway(GO:0022400) |
| 0.0 |
1.4 |
GO:0018146 |
keratan sulfate biosynthetic process(GO:0018146) |
| 0.0 |
0.3 |
GO:0071421 |
manganese ion transmembrane transport(GO:0071421) |
| 0.0 |
0.2 |
GO:0050917 |
sensory perception of umami taste(GO:0050917) |
| 0.0 |
0.9 |
GO:0042044 |
fluid transport(GO:0042044) |
| 0.0 |
0.3 |
GO:0071711 |
basement membrane organization(GO:0071711) |
| 0.0 |
0.3 |
GO:0032486 |
Rap protein signal transduction(GO:0032486) |
| 0.0 |
0.2 |
GO:1904491 |
protein localization to ciliary transition zone(GO:1904491) |
| 0.0 |
0.2 |
GO:0042048 |
olfactory behavior(GO:0042048) |
| 0.0 |
0.1 |
GO:0014028 |
notochord formation(GO:0014028) |
| 0.0 |
0.5 |
GO:0032526 |
response to retinoic acid(GO:0032526) |
| 0.0 |
3.5 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) |
| 0.0 |
0.2 |
GO:0098779 |
mitophagy in response to mitochondrial depolarization(GO:0098779) |
| 0.0 |
0.2 |
GO:0048340 |
paraxial mesoderm morphogenesis(GO:0048340) |
| 0.0 |
0.5 |
GO:0003323 |
type B pancreatic cell development(GO:0003323) |
| 0.0 |
0.3 |
GO:0000712 |
resolution of meiotic recombination intermediates(GO:0000712) |
| 0.0 |
0.1 |
GO:2000623 |
regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
| 0.0 |
0.1 |
GO:1901419 |
regulation of vitamin D receptor signaling pathway(GO:0070562) regulation of response to alcohol(GO:1901419) |
| 0.0 |
0.6 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) |
| 0.0 |
0.2 |
GO:0050689 |
negative regulation of defense response to virus by host(GO:0050689) |
| 0.0 |
0.2 |
GO:1903318 |
negative regulation of protein processing(GO:0010955) negative regulation of protein maturation(GO:1903318) |
| 0.0 |
0.1 |
GO:0032231 |
regulation of actin filament bundle assembly(GO:0032231) |
| 0.0 |
0.7 |
GO:0033120 |
positive regulation of RNA splicing(GO:0033120) |
| 0.0 |
1.2 |
GO:0008333 |
endosome to lysosome transport(GO:0008333) |
| 0.0 |
1.0 |
GO:1903146 |
regulation of mitophagy(GO:1903146) |
| 0.0 |
0.1 |
GO:0051151 |
negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 |
0.3 |
GO:0035176 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) |
| 0.0 |
0.1 |
GO:0032757 |
positive regulation of interleukin-8 production(GO:0032757) |
| 0.0 |
0.5 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.3 |
GO:0060711 |
labyrinthine layer development(GO:0060711) |
| 0.0 |
0.0 |
GO:0002024 |
diet induced thermogenesis(GO:0002024) |
| 0.0 |
0.5 |
GO:0008053 |
mitochondrial fusion(GO:0008053) |
| 0.0 |
0.1 |
GO:0007250 |
activation of NF-kappaB-inducing kinase activity(GO:0007250) |
| 0.0 |
0.1 |
GO:0072321 |
chaperone-mediated protein transport(GO:0072321) |
| 0.0 |
0.1 |
GO:0010665 |
regulation of striated muscle cell apoptotic process(GO:0010662) negative regulation of striated muscle cell apoptotic process(GO:0010664) regulation of cardiac muscle cell apoptotic process(GO:0010665) negative regulation of cardiac muscle cell apoptotic process(GO:0010667) |
| 0.0 |
0.2 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.7 |
GO:0006853 |
carnitine shuttle(GO:0006853) |
| 0.0 |
0.1 |
GO:0048266 |
behavioral response to pain(GO:0048266) |
| 0.0 |
0.1 |
GO:0055005 |
ventricular cardiac myofibril assembly(GO:0055005) |
| 0.0 |
1.0 |
GO:0045197 |
establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.0 |
0.2 |
GO:0071692 |
protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
| 0.0 |
0.2 |
GO:0035771 |
interleukin-4-mediated signaling pathway(GO:0035771) |
| 0.0 |
0.3 |
GO:0090023 |
positive regulation of neutrophil chemotaxis(GO:0090023) |
| 0.0 |
0.1 |
GO:0048511 |
rhythmic process(GO:0048511) |
| 0.0 |
0.3 |
GO:2000271 |
positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.0 |
0.2 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:0003221 |
right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
| 0.0 |
0.4 |
GO:0051412 |
response to corticosterone(GO:0051412) |
| 0.0 |
0.5 |
GO:0051382 |
kinetochore assembly(GO:0051382) |
| 0.0 |
0.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.3 |
GO:0001833 |
inner cell mass cell proliferation(GO:0001833) |
| 0.0 |
0.4 |
GO:0006703 |
estrogen biosynthetic process(GO:0006703) |
| 0.0 |
0.4 |
GO:0007213 |
G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) acetylcholine receptor signaling pathway(GO:0095500) postsynaptic signal transduction(GO:0098926) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.0 |
0.2 |
GO:0061418 |
regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
| 0.0 |
0.1 |
GO:0097012 |
cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) response to granulocyte macrophage colony-stimulating factor(GO:0097012) |
| 0.0 |
0.5 |
GO:2000369 |
regulation of clathrin-mediated endocytosis(GO:2000369) |
| 0.0 |
0.7 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.2 |
GO:0006177 |
GMP biosynthetic process(GO:0006177) |
| 0.0 |
0.3 |
GO:0022410 |
circadian sleep/wake cycle process(GO:0022410) circadian sleep/wake cycle, sleep(GO:0050802) |
| 0.0 |
0.6 |
GO:0016486 |
peptide hormone processing(GO:0016486) |
| 0.0 |
0.1 |
GO:0046092 |
deoxycytidine metabolic process(GO:0046092) |
| 0.0 |
0.0 |
GO:0033686 |
positive regulation of luteinizing hormone secretion(GO:0033686) |
| 0.0 |
0.2 |
GO:0006543 |
glutamine catabolic process(GO:0006543) |
| 0.0 |
0.3 |
GO:0040037 |
negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
| 0.0 |
0.1 |
GO:0034315 |
regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
| 0.0 |
0.1 |
GO:0006878 |
cellular copper ion homeostasis(GO:0006878) |
| 0.0 |
0.3 |
GO:0046950 |
cellular ketone body metabolic process(GO:0046950) |
| 0.0 |
0.2 |
GO:0000380 |
alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.0 |
0.2 |
GO:0090151 |
establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.0 |
0.2 |
GO:0036152 |
phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
| 0.0 |
0.4 |
GO:0043981 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.0 |
0.5 |
GO:0051290 |
protein heterotetramerization(GO:0051290) |
| 0.0 |
0.3 |
GO:0007623 |
circadian rhythm(GO:0007623) |
| 0.0 |
0.7 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.1 |
GO:0031065 |
positive regulation of histone deacetylation(GO:0031065) |
| 0.0 |
0.1 |
GO:0060254 |
regulation of N-terminal protein palmitoylation(GO:0060254) negative regulation of N-terminal protein palmitoylation(GO:0060262) negative regulation of protein lipidation(GO:1903060) |
| 0.0 |
0.3 |
GO:0071493 |
cellular response to UV-B(GO:0071493) |
| 0.0 |
0.2 |
GO:0001574 |
ganglioside biosynthetic process(GO:0001574) |
| 0.0 |
0.3 |
GO:0008344 |
adult locomotory behavior(GO:0008344) |
| 0.0 |
0.2 |
GO:0000012 |
single strand break repair(GO:0000012) |
| 0.0 |
0.3 |
GO:0046085 |
adenosine metabolic process(GO:0046085) |
| 0.0 |
0.1 |
GO:0048745 |
smooth muscle tissue development(GO:0048745) |
| 0.0 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.0 |
1.1 |
GO:0043484 |
regulation of RNA splicing(GO:0043484) |
| 0.0 |
0.1 |
GO:0032290 |
peripheral nervous system myelin formation(GO:0032290) |
| 0.0 |
0.1 |
GO:0010634 |
positive regulation of epithelial cell migration(GO:0010634) |
| 0.0 |
1.4 |
GO:0009301 |
snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
| 0.0 |
0.1 |
GO:2000785 |
regulation of autophagosome assembly(GO:2000785) |
| 0.0 |
0.2 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.2 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.0 |
0.4 |
GO:0001913 |
T cell mediated cytotoxicity(GO:0001913) |
| 0.0 |
0.1 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.0 |
0.0 |
GO:2000418 |
positive regulation of eosinophil migration(GO:2000418) |
| 0.0 |
0.2 |
GO:0046007 |
negative regulation of activated T cell proliferation(GO:0046007) |
| 0.0 |
0.0 |
GO:1902075 |
cellular response to salt(GO:1902075) |
| 0.0 |
0.1 |
GO:0006942 |
regulation of striated muscle contraction(GO:0006942) |
| 0.0 |
0.1 |
GO:0008295 |
spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.3 |
GO:0043162 |
ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.0 |
0.0 |
GO:0002232 |
leukocyte chemotaxis involved in inflammatory response(GO:0002232) |
| 0.0 |
0.3 |
GO:0042572 |
retinol metabolic process(GO:0042572) |
| 0.0 |
0.1 |
GO:0043388 |
positive regulation of DNA binding(GO:0043388) |
| 0.0 |
0.1 |
GO:0034378 |
chylomicron assembly(GO:0034378) |
| 0.0 |
0.1 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.0 |
0.3 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0071688 |
myosin filament organization(GO:0031033) myosin filament assembly(GO:0031034) striated muscle myosin thick filament assembly(GO:0071688) |
| 0.0 |
0.1 |
GO:0016081 |
synaptic vesicle docking(GO:0016081) |
| 0.0 |
0.4 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.0 |
0.2 |
GO:0006528 |
asparagine metabolic process(GO:0006528) |
| 0.0 |
0.1 |
GO:0006656 |
phosphatidylcholine biosynthetic process(GO:0006656) |
| 0.0 |
0.1 |
GO:1901160 |
primary amino compound metabolic process(GO:1901160) |
| 0.0 |
0.2 |
GO:0050808 |
synapse organization(GO:0050808) |
| 0.0 |
0.1 |
GO:0001787 |
natural killer cell proliferation(GO:0001787) NK T cell proliferation(GO:0001866) |
| 0.0 |
0.1 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.5 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.0 |
0.0 |
GO:0043968 |
histone H2A acetylation(GO:0043968) |
| 0.0 |
0.1 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.2 |
GO:0006307 |
DNA dealkylation involved in DNA repair(GO:0006307) |
| 0.0 |
0.1 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.0 |
0.2 |
GO:0043537 |
negative regulation of blood vessel endothelial cell migration(GO:0043537) |
| 0.0 |
0.1 |
GO:0060009 |
Sertoli cell development(GO:0060009) |
| 0.0 |
0.1 |
GO:0098758 |
interleukin-8-mediated signaling pathway(GO:0038112) response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
| 0.0 |
0.2 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.2 |
GO:0006071 |
glycerol metabolic process(GO:0006071) |
| 0.0 |
0.1 |
GO:0052551 |
response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
| 0.0 |
0.1 |
GO:0010960 |
magnesium ion homeostasis(GO:0010960) |
| 0.0 |
0.1 |
GO:0090190 |
positive regulation of branching involved in ureteric bud morphogenesis(GO:0090190) |
| 0.0 |
0.0 |
GO:1905053 |
regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
| 0.0 |
0.1 |
GO:0006432 |
phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.0 |
0.0 |
GO:0050976 |
detection of mechanical stimulus involved in sensory perception of touch(GO:0050976) |
| 0.0 |
0.0 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.0 |
0.1 |
GO:0035116 |
embryonic hindlimb morphogenesis(GO:0035116) |
| 0.0 |
0.3 |
GO:0042149 |
cellular response to glucose starvation(GO:0042149) |
| 0.0 |
0.3 |
GO:0097186 |
amelogenesis(GO:0097186) |
| 0.0 |
0.7 |
GO:0006970 |
response to osmotic stress(GO:0006970) |
| 0.0 |
0.1 |
GO:0071447 |
cellular response to hydroperoxide(GO:0071447) |
| 0.0 |
0.1 |
GO:0006828 |
manganese ion transport(GO:0006828) |
| 0.0 |
0.2 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.0 |
0.6 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.1 |
GO:0010288 |
response to lead ion(GO:0010288) |
| 0.0 |
0.1 |
GO:0002074 |
extraocular skeletal muscle development(GO:0002074) |
| 0.0 |
0.1 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) |
| 0.0 |
0.0 |
GO:2000567 |
memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
| 0.0 |
0.3 |
GO:0070328 |
acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.0 |
0.1 |
GO:0044070 |
regulation of anion transport(GO:0044070) |
| 0.0 |
0.1 |
GO:0032633 |
interleukin-4 production(GO:0032633) |
| 0.0 |
0.0 |
GO:0014041 |
regulation of neuron maturation(GO:0014041) |
| 0.0 |
0.0 |
GO:0043043 |
peptide biosynthetic process(GO:0043043) |
| 0.0 |
0.1 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.0 |
0.1 |
GO:0070373 |
negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
| 0.0 |
0.1 |
GO:0018231 |
peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
| 0.0 |
0.0 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.0 |
0.0 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
